- Home
- About Us
Technologies & Platforms
- Full Cycle Genetic
Testing SolutionsClinical Genetic Testing Solutions
LDT Services
- Pan-Cancer Genetic Testing Assays
- Minimal Residual Disease (MRD) Detection Assays
- Specific-Cancer Genetic Testing Assays
IVD Products
Non-clinical Genetic Testing Solutions
Comprehensive Health Risk Assessment Solutions
- R&D Genetic
Testing Solutions - Pathogenic Microbe Genetic
Testing Solutions - Contact Us
- Home
- About Us
- Introduction
- Mission and Vision
- Technologies & Platforms +
- Patents & Copyrights
- Full Cycle Genetic
Testing Solutions-
Clinical Genetic Testing Solutions
+
- Clinical Genetic Testing Solutions Overview
- Pan-Cancer Genetic Testing Assays +
- Minimal Residual Disease (MRD) Detection Assays +
- Specific-Cancer Genetic Testing Assays +
- Clinical Genetic Testing Solutions Overview
- Non-clinical Genetic Testing Solutions +
-
One-stop Solutions
+
-
Medical Devices
+
- HapOnco® LungCDx EGFR/ALK NGS Testing Kit
(Reversible termination sequencing technology) - Analytical Software for Non-Small Cell Lung Cancer Gene Variation
- Nucleic Acid Extraction Reagent
(Magnetic bead method, suitable for EDTA anticoagulant tubes or Streck blood collection tubes, used for plasma cfDNA extraction) - Nucleic Acid Extraction Reagent
(Magnetic bead method, suitable for FFPE samples, used for gDNA extraction) - Nucleic Acid Extraction Reagent
(Magnetic bead method, suitable for whole blood samples, used for gDNA extraction) - Nucleic Acid Extraction Reagent
(Magnetic bead method, suitable for Streck blood collection tubes, used for plasma cfDNA extraction)
- HapOnco® LungCDx EGFR/ALK NGS Testing Kit
-
Medical Devices
+
-
Clinical Genetic Testing Solutions
+
- R&D Genetic
Testing Solutions - Pathogenic Microbe Genetic
Testing Solutions - Contact Us
HaploX GrowthCipher Genetic Test
Non-clinical Genetic Testing Solutions
HaploX GrowthCipher Genetic Test
Testing Content
HaploX GrowthCipher Genetic Test includes screening for 565 common hereditary monogenic diseases in pediatrics (such as G6PD deficiency), aiming for early detection and prevention.
Applicable Population
1. Infants, children and adolescents.
2. Individuals with a family history of genetic diseases.
customer_service@haplox.net
Copyright © 2024 HaploX. All Rights Reserved.